Pegylated liposomal doxorubicin (Duomeisu ® ) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study.
Hanfang JiangHuiping LiGuohong SongLijun DiBin ShaoYing YanXiaoran LiuYifei ChenRuyan ZhangRan RanYaxin LiuXinyu GuiNan WangHuan WangPublished in: Breast cancer research and treatment (2023)
every 4 weeks was effective and well-tolerated in patients with HER2-negative MBC heavily pretreated with anthracycline and taxanes, revealing a potentially viable treatment option for this population. Trial registration Chinese Clinical Trial Registry: ChiCTR1900022568.